Management of Refractory Variceal Bleeding

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Fifteen to 20% of patients with cirrhosis and variceal bleeding will develop refractory bleeding, i.e., persistent bleeding despite the use of vasoactive treatment, antibiotics, and endoscopic treatment. In this situation, Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the best therapeutic option. As TIPS may not be immediately available, temporary procedures such as balloon tamponade or oesophageal stents have to be used as “bridge therapy” to control bleeding. In this review, the current data on these different options are analyzed.

Cite

CITATION STYLE

APA

Rudler, M. (2022). Management of Refractory Variceal Bleeding. In Portal Hypertension VII: Proceedings of the 7th Baveno Consensus Workshop: Personalized Care in Portal Hypertension (pp. 477–483). Springer International Publishing. https://doi.org/10.1007/978-3-031-08552-9_41

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free